Lori M. Reilly is Executive Vice President for Policy, Research and Membership at the Pharmaceutical Research and Manufacturers of America (PhRMA). Ms. Reilly heads PhRMA’s policy and research department in the development and implementation of legislative, regulatory and political strategies to successfully navigate the ever-changing federal health care landscape, working to advance policies that encourage medical progress and patient access to the fruits of pharmaceutical innovation. In her membership role, Ms. Reilly leads the association’s efforts to grow the depth and breadth of innovative pharmaceutical company membership and engagement.
In addition to her public policy work, Ms. Reilly is a frequent presenter on industry-related issues and is an industry spokesperson. Ms. Reilly testified before the House Energy and Commerce Subcommittee on Health to discuss the importance of the reauthorization of the pediatric exclusivity program and the Food and Drug Administration Globalization Act.
Prior to joining PhRMA, she was counsel at the U.S. House of Representatives Committee on Commerce. And before joining the House Commerce Committee, Ms. Reilly was Chief of Staff/Counsel to Rep. Jon Christensen, a member of the House Ways and Means Committee.
Ms. Reilly is currently a Board Member for the Pharmacy Quality Alliance (PQA) and a member of the National Quality Forum (NQF) Policy Advisors. Ms. Reilly is also a 2016 Honoree of the Irish America Healthcare and Life Sciences 50.
Ms. Reilly received a B.A. in Political Science from the University of Nebraska-Lincoln where she graduated with Honors, and a J.D. from the University of Nebraska College of Law. She is a Member of the Virginia Bar and currently resides in Alexandria, Virginia with her husband and their four children.